The Heidelberg Metabolomics Symposium will bring together international, national and local experts in the field of Metabolomics, Cancer and Immunology research to discuss the current state of the art in the metabolomics field and to discuss future outlooks.

The aim of DGMet (Deutsche Gesellschaft für Metabolomforschung) is to foster research in metabolism and to function as an interaction platform for scientists in the field. For this reason, the society organizes a general yearly conference and smaller workshops for the society’s study groups. 

Join us for the annual symposium APMRS 2023 of the Austrian Proteomics and Metabolomics Association (APMA) in Innsbruck, Austria, in 2023. This symposium will gather researchers, scientists, and experts in the field of proteomics and metabolomics for an enriching exchange of ideas and collaborations.

Advances in proteomics and metabolomics will once again bring together leading scientists in the field as they highlight the latest advancements in translational proteomics and metabolomics. Presentations will cover areas ranging from uncovering the molecular mechanisms of disease pathology, to the latest technological developments in diagnostics and treatment.

The Munich Metabolomics Meeting is offering two days of news and research around metabolomics and lipidomics, including a workshop for PhD students and PostDocs.

The annual conference of the Nordic Metabolomics Society aims to highlight and discuss the latest metabolomics research in the Nordic countries and abroad. This year the conference will be held in Trondheim, Norway, at the hotel Scandic Nidelven.

Meet biocrates at 5th Annual MANA Conference 2023.

The liver meeting convenes attendees from around the world to learn about the latest advances in hepatology from experts in the field, explore cutting-edge technology and solutions, renew connections, build new relationships.

For the Metabolomics HEALTH Meeting Graz, we have invited local and international speakers who will present the wide range of metabolomics applications. From novel model systems and experimental approaches to biomarker research, talks will discuss the role of metabolomics in the future of precision medicine.

Microbiome Connect provides the chance to address shared challenges around innovative therapeutic development, build meaningful partnerships, and sharpen their R&D and commercial strategies. Bringing together the whole microbiome therapeutics ecosystem – from investors and large pharmaceutical companies through to the most pioneering biotechs, academic institutions and solution providers – it delivers the business-critical information you need to make strategic decisions for your organisation through in-depth case studies and expanded networking opportunities.